AAD 2026视频特辑
皮科洞见
【前沿资讯】不适合强化化疗的IDH突变AML患者采用去甲基化药物、维奈克拉联合IDH抑制剂一线三联方案的疗效评估
Htology血液前沿 | 2025-08-22
Copyright (C) 2026 by eDoctor Healthcare Communications. All Rights Reserved.
沪公网安备31010502003091号 | 沪ICP备11005620号-15